{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:43:51Z","timestamp":1791330231321,"version":"4.3.1"},"reference-count":118,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.critrevonc.2008.07.021","type":"journal-article","created":{"date-parts":[[2008,9,21]],"date-time":"2008-09-21T13:41:42Z","timestamp":1222004502000},"page":"183-194","source":"Crossref","is-referenced-by-count":204,"title":["Infections and cancer: Established associations and new hypotheses"],"prefix":"10.1016","volume":"70","author":[{"given":"Catherine","family":"de Martel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2008.07.021_bib1","first-page":"387","article-title":"Cancer and infection: estimates of the attributable fraction in 1990","volume":"6","author":"Pisani","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib2","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib3","series-title":"GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide, IARC CancerBase No. 5, version 2.0","author":"Ferlay","year":"2004"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib4","series-title":"Schistosomes liver flukes and Helicobacter pylori, vol. 61","article-title":"IARC monographs on the evaluation of carcinogenic risks to humans","year":"1994"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/427659","article-title":"Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma","volume":"191","author":"de Martel","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.49.3.347","article-title":"Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts","volume":"49","author":"Helicobacter and Cancer Collaborative Group","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/368133","article-title":"Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma","volume":"187","author":"Semino-Mora","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib8","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/jnci\/djm120","article-title":"Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions","volume":"99","author":"Plummer","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib9","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/jnci\/94.22.1680","article-title":"Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma","volume":"94","author":"Figueiredo","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/35006081","article-title":"Interleukin-1 polymorphisms associated with increased risk of gastric cancer","volume":"404","author":"El-Omar","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ijc.21822","article-title":"A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study","volume":"119","author":"Shikata","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib12","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/j.gastro.2007.06.026","article-title":"Carcinogenesis of Helicobacter pylori","volume":"133","author":"Correa","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib13","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1126\/science.1099513","article-title":"Gastric cancer originating from bone marrow-derived cells","volume":"306","author":"Houghton","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.291.2.187","article-title":"Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial","volume":"291","author":"Wong","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1158\/1055-9965.EPI-03-0124","article-title":"Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial","volume":"13","author":"Ley","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib16","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1136\/gut.2003.034629","article-title":"Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication","volume":"53","author":"Leung","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib17","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jnci\/92.23.1881","article-title":"Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy","volume":"92","author":"Correa","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib18","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/jnci\/djj264","article-title":"Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions","volume":"98","author":"You","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jnci\/djk017","article-title":"Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population","volume":"99","author":"Plummer","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3201\/eid0603.000302","article-title":"A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States","volume":"6","author":"Rupnow","year":"2000","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4065\/83.2.169","article-title":"Helicobacter pylori vaccine: from past to future","volume":"83","author":"Agarwal","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/jnci\/djh102","article-title":"Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas","volume":"96","author":"Ferreri","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib23","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1182\/blood-2005-09-3679","article-title":"Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation","volume":"107","author":"Suarez","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa031887","article-title":"Immunoproliferative small intestinal disease associated with Campylobacter jejuni","volume":"350","author":"Lecuit","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib25","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1056\/NEJM199405053301803","article-title":"Helicobacter pylori infection and gastric lymphoma","volume":"330","author":"Parsonnet","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib26","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/jnci\/dji277","article-title":"Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma","volume":"97","author":"Chen","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib27","series-title":"Human papilloma viruses, vol. 90","article-title":"IARC monographs on the evaluation of carcinogenic risks to humans","year":"2007"},{"issue":"Suppl. 3","key":"10.1016\/j.critrevonc.2008.07.021_bib28","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"Chapter 2: the burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/524875","article-title":"Risk of female human papillomavirus acquisition associated with first male sex partner","volume":"197","author":"Winer","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib31","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/516784","article-title":"A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion","volume":"195","author":"Plummer","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib32","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","article-title":"Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis","volume":"366","author":"Clifford","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib33","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/ije\/dyn033","article-title":"Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys","volume":"37","author":"Vaccarella","year":"2008","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ijc.23045","article-title":"Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya","volume":"122","author":"De Vuyst","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib35","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1158\/1055-9965.EPI-06-0556","article-title":"Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys","volume":"15","author":"Vaccarella","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib36","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/01.aids.0000253361.63578.14","article-title":"Human papillomavirus types among women infected with HIV: a meta-analysis","volume":"20","author":"Clifford","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/528379","article-title":"Circumcision and human papillomavirus infection in men: a site-specific comparison","volume":"197","author":"Hernandez","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib38","series-title":"Human papillomaviruses, vol. 64","article-title":"IARC monographs on the evaluation of carcinogenic risks to humans","year":"1995"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1126\/science.2157286","article-title":"Association of human papillomavirus types 16 and 18 E6 proteins with p53","volume":"248","author":"Werness","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","article-title":"Chapter 1: human papillomavirus and cervical cancer\u2014burden and assessment of causality","author":"Bosch","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ijc.20257","article-title":"Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case\u2013control study","volume":"111","author":"Smith","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib42","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/ijc.21953","article-title":"Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies","volume":"119","author":"International Collaboration of Epidemiological Studies of Cervical Cancer","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib43","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/ijc.21493","article-title":"Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies","volume":"118","author":"Appleby","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib44","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","article-title":"Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies","volume":"370","author":"Appleby","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib45","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.ygyno.2008.02.001","article-title":"The current and future role of screening in the era of HPV vaccination","volume":"109","author":"Myers","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib46","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib47","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib48","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2471\/BLT.06.038414","article-title":"Human papillomavirus and HPV vaccines: a review","volume":"85","author":"Cutts","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib49","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib50","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial","volume":"298","author":"Hildesheim","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib51","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/epirev\/mxj009","article-title":"Hepatitis B virus infection: epidemiology and vaccination","volume":"28","author":"Shepard","year":"2006","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib52","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1097\/00004836-200411003-00008","article-title":"Global epidemiology of hepatitis B virus","volume":"38","author":"Custer","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib53","first-page":"425","article-title":"Hepatitis C\u2014global prevalence (update)","volume":"74","year":"1999","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib54","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1086\/522608","article-title":"Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance","volume":"196","author":"Wang","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0091270003258669","article-title":"Global burden of disease (GBD) for hepatitis C","volume":"44","author":"The Global Burden Of Hepatitis C Working Group","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib57","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/sj.bjc.6603649","article-title":"Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review","volume":"96","author":"Raza","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib58","series-title":"Hepatitis viruses, vol. 59","article-title":"IARC monographs on the evaluation of carcinogenic risks to human","year":"1994"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib60","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment","volume":"6","author":"Farazi","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib61","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/(SICI)1097-0215(19980130)75:3<347::AID-IJC4>3.0.CO;2-2","article-title":"A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma","volume":"75","author":"Donato","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib62","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhep.2008.03.012","article-title":"Mouse models for the study of HCV infection and virus\u2013host interactions","volume":"49","author":"Barth","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib63","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/90968","article-title":"Hepatitis C virus replication in mice with chimeric human livers","volume":"7","author":"Mercer","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib64","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal Hepatitis B Vaccination in Taiwan and the incidence of hepatocellular carcinoma in children","volume":"336","author":"Chang","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib65","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bmj.325.7364.569","article-title":"Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children","volume":"325","author":"Whittle","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib66","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1053\/j.gastro.2007.02.055","article-title":"Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies","volume":"132","author":"Ni","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib67","unstructured":"Global Immunization coverage. WHO\/UNICEF coverage estimates, 1980\u20132006, as of August 2007 (http:\/\/www.who.int\/immunization\/newsroom\/Global_Immunization_Data.pdf\u2013accessed on 31-1-0008)."},{"key":"10.1016\/j.critrevonc.2008.07.021_bib68","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/10428190290016845","article-title":"Hepatitis C virus, B-cell proliferation and lymphomas","volume":"43","author":"Gasparotto","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib69","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","article-title":"Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies","volume":"15","author":"DalMaso","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib70","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/(SICI)1096-8652(200006)64:2<95::AID-AJH4>3.0.CO;2-A","article-title":"Hepatitis C virus in non-Hodgkin's lymphoma. A reappraisal after a prospective case\u2013control study of 300 patients. Lombart Study Group of HCV-Lymphoma","volume":"64","author":"Pioltelli","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib71","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1349-7006.2002.tb01280.x","article-title":"Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case\u2013control study","volume":"93","author":"Kim","year":"2002","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib72","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.20137","article-title":"Non-Hodgkin's lymphoma and hepatitis C virus: a case\u2013control study from northern and southern Italy","volume":"110","author":"Talamini","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib73","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.21642","article-title":"Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection","volume":"46","author":"Ulcickas","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib74","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib75","series-title":"Epstein-Barr virus and Kaposi's sarcoma herpesvirus\/human herpesvirus 8, vol. 70","article-title":"IARC monographs on the evaluation of carcinogenic risks to humans","year":"1997"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib76","first-page":"166","article-title":"Burkitt's lymphoma in Africa, a review of the epidemiology and etiology","volume":"7","author":"Orem","year":"2007","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib77","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/274756a0","article-title":"Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study","volume":"274","author":"de-The","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib78","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/ijc.23254","article-title":"Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case\u2013control study in Uganda","volume":"122","author":"Carpenter","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib79","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0092-8674(86)90803-2","article-title":"The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation","volume":"47","author":"Raab-Traub","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib80","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1055-9965.EPI-06-0353","article-title":"The enigmatic epidemiology of nasopharyngeal carcinoma","volume":"15","author":"Chang","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib81","series-title":"Cancer incidence in five continents, vol. IX. IARC scientific publications no. 160","author":"Curado","year":"2007"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib82","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa011610","article-title":"Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men","volume":"345","author":"Chien","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib83","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/jcp.2007.050146","article-title":"Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma","volume":"60","author":"Kapatai","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib84","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM198903163201103","article-title":"Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis","volume":"320","author":"Mueller","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib85","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib86","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/QAD.0b013e3282f46582","article-title":"No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population","volume":"22","author":"Malope","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib87","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/QAI.0b013e31802f12ea","article-title":"Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children in a South African population","volume":"44","author":"Malope","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib88","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/jcp.2007.047969","article-title":"Kaposi sarcoma-associated herpesvirus\/human herpesvirus 8 and lymphoproliferative disorders","volume":"60","author":"Du","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib89","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nri2076","article-title":"Immune evasion by Kaposi's sarcoma-associated herpesvirus","volume":"7","author":"Coscoy","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib90","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev.micro.57.030502.090824","article-title":"Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?","volume":"57","author":"Moore","year":"2003","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib91","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/CMR.15.2.310-326.2002","article-title":"Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma","volume":"15","author":"Barillari","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib92","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2007.12.025","article-title":"Human herpesvirus 8 load and progression of AIDS-related Kaposi sarcoma lesions","volume":"263","author":"Nsubuga","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib93","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1056\/NEJMc070508","article-title":"HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load","volume":"357","author":"Maurer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib94","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/294268a0","article-title":"Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukaemia","volume":"294","author":"Poiesz","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib95","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib96","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","article-title":"Human T-lymphotropic virus 1: recent knowledge about an ancient infection","volume":"7","author":"Verdonck","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib97","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1080115","article-title":"Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton","volume":"299","author":"Igakura","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib98","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ijc.2910430214","article-title":"Modelling the risk of adult T-cell leukemia\/lymphoma in persons infected with human T-lymphotropic virus type I","volume":"43","author":"Murphy","year":"1989","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib99","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases","volume":"24","author":"Proietti","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib100","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib101","series-title":"Human immunodeficiency viruses and human T-cell lymphotropic viruses, vol. 67","article-title":"IARC monographs on the evaluation of carcinogenic risks to humans","year":"1996"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib102","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3201\/eid1110.050614","article-title":"Emerging foodborne trematodiasis","volume":"11","author":"Keiser","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib103","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ijc.2910480302","article-title":"Liver cancer in Thailand. I. A case\u2013control study of cholangiocarcinoma","volume":"48","author":"Parkin","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib104","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.21146","article-title":"Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand","volume":"117","author":"Honjo","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1471-2164-8-189","article-title":"Gene discovery for the carcinogenic human liver fluke, Opisthorchis viverrini","volume":"8","author":"Laha","year":"2007","journal-title":"BMC Genomics"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib106","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4269\/ajtmh.2006.75.93","article-title":"Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea","volume":"75","author":"Lim","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib107","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0001-706X(03)00029-9","article-title":"Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa","volume":"86","author":"van der Werf","year":"2003","journal-title":"Acta Trop"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib108","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1128\/CMR.12.1.97","article-title":"Relationship between schistosomiasis and bladder cancer","volume":"12","author":"Mostafa","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib109","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djm010","article-title":"AIDS-related cancer and severity of immunosuppression in persons with AIDS","volume":"99","author":"Biggar","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib111","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy","volume":"97","author":"Clifford","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib112","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States","volume":"123","author":"Engels","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib113","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","article-title":"Clonal integration of a polyomavirus in human Merkel cell carcinoma","volume":"319","author":"Feng","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib114","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1200\/JCO.2005.03.7101","article-title":"Is there a role for SV40 in human cancer?","volume":"24","author":"Poulin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib115","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.21683","article-title":"Gallbladder cancer worldwide: geographical distribution and risk factors","volume":"118","author":"Randi","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib116","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1473-3099(08)70066-5","article-title":"Helicobacter species and liver diseases: association or causation?","volume":"8","author":"Pellicano","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib117","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(88)90867-7","article-title":"Evidence for an infective cause of childhood leukaemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain","volume":"2","author":"Kinlen","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2008.07.021_bib118","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc1816","article-title":"Infection, immune responses and the aetiology of childhood leukaemia","volume":"6","author":"Greaves","year":"2006","journal-title":"Nat Rev Cancer"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842808001777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842808001777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T04:11:44Z","timestamp":1557807104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842808001777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":118,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S1040842808001777"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2008.07.021","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}